Drug Development Pharma 608 Views AstraZeneca’s Lynparza granted Priority Review in the US Malin Otmani November 30, 2021 AstraZeneca’s supplemental New Drug Application …
Drug Development Pharma 517 Views Cyxone announces promising preclinical results Malin Otmani October 27, 2021 Cyxone, together with its academic …
Drug Development Pharma 539 Views Elicera Therapeutics presents preclinical proof-of-concept data Malin Otmani October 20, 2021 Elicera Therapeutics has presented preclinical …
Drug Development Pharma 783 Views AlzeCure Pharma presents new data Malin Otmani October 5, 2021 AlzeCure Pharma has presented new …
Drug Development Pharma 1154 Views TILT Biotherapeutics announces publication of pre-clinical data Malin Otmani August 27, 2021 New preclinical data relating to …
Clinical Trials 1723 Views Immunicum advances its Phase Ib/II combination trial Malin Otmani June 15, 2020 Immunicum has announced that the …
Clinical Trials 2845 Views Affibody terminates program and announces positive data from another Malin Otmani June 15, 2020 Affibody has announced the completion …
Drug Development Pharma 2117 Views Betalutin receives positive EMA opinion Malin Otmani May 19, 2020 Nordic Nanovector has announced that …
Drug Development Pharma 1162 Views Oncopeptides announces new data Malin Otmani May 18, 2020 Oncopeptides has announced that data …
Drug Development Pharma 1385 Views Sprint Bioscience announces positive data Malin Otmani May 5, 2020 Sprint Bioscience has announced that …
Clinical Trials 1556 Views Medivir phase II study published in Annals of Internal Medicine Malin Otmani January 22, 2020 Medivir has announced that the …
Drug Development Pharma 1404 Views Idogen’s cell technology advanced to large-scale production Malin Otmani January 20, 2020 Idogen has announced that the …
Drug Development Pharma 1905 Views New study shows Sigrid’s medical device prevents weight gain Malin Otmani January 16, 2020 Sigrid Therapeutics has announced the …
Drug Development Pharma 1468 Views FDA approval for Genmab’s Darzalex in combination with Bortezomib, Thalidomide and Dexamethasone Malin Otmani October 2, 2019 Genmab has announced that the …
Agreement 2017 Views Zealand Pharma and Boehringer Ingelheim initiate Phase 2 development of BI 456906 Malin Otmani September 4, 2019 Boehringer Ingelheim plans to initiate …
Drug Development Pharma 1549 Views FDA grants Fast Track designation for AstraZeneca’s Farxiga Malin Otmani August 28, 2019 The US Food and Drug …